KCAS uses cutting edge technologies, including the Simoa by Quanterix, to address some of our client’s most challenging assay goals for PK and biomarker testing.
Our highly active method development team has developed and validated 4,600+ proprietary and 900+ non-proprietary bioanalytical assays.Read more
September 2017 Kansas City’s Top Animal Health Companies, #7 [article]
4 August 2017 KCAS Welcomes Frank Spriggs [press release]
28 April 2017 KCAS Bioanalytical and Biomarker Services Now Offers Ultra-Sensitive Validated Assay for Nicotine Studies [press release]
25 January 2017 KCAS Welcomes Buddy Worrell…